| INTRODUCTION
Normal term parturition in human is initiated when fetal organ systems reach maturity around 37-40 weeks' gestation. Conventional theories of initiation signaling of parturition are primarily linked to feto-maternal endocrine and immune changes in the intra-uterine cavity correlating with fetal growth and development. 1 Recently, we have reported fetal tissue senescence, correlated with fetal growth generating sterile inflammatory markers that can be propagated as paracrine fetal signals associated with parturition. 2 Homeostatic imbalances produced by both endocrine and paracrine factors produce an inflammatory overload that disrupts the maintenance of pregnancy. These signals transition a quiescent myometrium into an active status. Nonetheless, the profile of these signals, whether fetal or maternal derived, and their precise mechanism in initiating parturition are still unclear.
Understanding these signals and their mechanisms in normal term pregnancies can provide insights into pathologic activation of signals that can induce spontaneous preterm labor. Inflammatory overload of various uterine tissues has been associated with preterm labor. 3 This inflammation is either infectious due to microbial invasion or sterile in the absence of microbes. 4 Infection is welldocumented to be involved in preterm labor, but the majority of preterm labor is associated with sterile inflammmation. 5 Both infectious and sterile inflammation share similar biochemical profile and are associated with an increased pro-inflammatory load though the amount and type of cytokines present differ. 3 Similarly, term parturition is also linked to sterile inflammation with similar biomarkers seen in various fetal and maternal biologic fluids. 2 Although differences may exist in the initiators of term and preterm parturition, similarities in the biomarkers suggest inflammation still drives the final effecter pathway resulting in labor and delivery. Inflammation is contributed by both fetal and maternal tissues, but the precise contributions of any of the uterine tissue are still unclear. 6, 7 The lack of reliable biomarkers to predict eminent labor either at term or preterm also suggests the need for a better understanding of inflammatory profile reported so far. Understanding the differences in the inflammatory biomarkers produced by each uterine tissue is expected to help us to better understand tissue-specific contributions to the overall load of inflammation as well as their unique inflammatory status during labor.
Our primary objective was to review the literature to identify biomarkers reported to be different at the time of normal term labor compared to term not in labor status in different gestational compartments, specifically, fetal membranes (amnion and chorion), placenta, decidua, and myometrium.
| METHODS
The systematic review was conducted according to the recommendations of the MOOSE group and reported in accordance with the PRISMA Statement. 8, 9 This systematic review was registered in PROSPERO (registration number CRD42015029470).
| Search methods for identification of studies
We performed a search for studies published from 1980 to December 2016, in English, indexed in the following electronic databases:
MEDLINE, EMBASE (via Ovid), Web of Science, and Cumulative Index to Nursing and Allied Health Literature (CINAHL).
The search strategy was developed with the assistance of a librarian team experienced in systematic reviews. The search strived to identify studies that provided information on inflammatory biomarker signature of intra-uterine compartments (fetal membranes, decidua, placenta, and myometrium) in healthy women at term, in labor and not in labor. The main key words, adapted to each search were as follows:
inflammation, term birth, term parturition, pregnancy, myometrium, placenta, fetal membranes, and decidua (See Table S1 for full details of the search).
| Selection criteria

| Types of studies
We included original studies on inflammatory biomarkers in human tissues of pregnancies at term (gestational age ≥37 weeks), of women in labor or not in labor. Studies using other models, including animal models and infectious models, of pregnancy were excluded. Studies were excluded if they focused exclusively on amniotic fluid samples, preterm labor, women with clinical signs of inflammation (fever, elevated C-reactive protein, foul-smelling vaginal discharge, and uterine tenderness), or with histologic signs of chorioamnionitis (presence of >3-4 polymorphonuclear leukocytes in the membranes). We excluded studies that did not provide adequate descriptions of biochemical measurements, review articles, and those that were published only as abstracts (eg, congress presentations).
| Types of participants
We included studies that collected samples from healthy women of any age, parity, or ethnicity, at full-term gestation (≥37 weeks) who were either in labor or not in labor at the time of specimen collection for assay and analysis. We excluded studies that enrolled only women with preterm labor and delivery (both spontaneous and induced) or with chorioamnionitis. Studies that utilized cell lines from the gestational tissues of interest were also included.
| Types of outcome measures
In this study, a biomarker is defined as physiologic or pathophysiologic biochemical or biomolecular alterations at the organ, tissue, cell, or subcellular level in response to an exposure that are measurable in biological samples and or in cell and tissue culture supernatants in an in vitro study that can become the signature of the onset of phenotypic outcome (ie, term labor or term not in labor).
We included studies that reported on the changes in biomarkers at the time of term labor as long as the outcome was related to term labor not complicated by chorioamnionitis. In addition, we also included studies reporting biomarker changes in vitro, in culture environment from normal term tissues collected at term (labor vs not in labor).
| Types of biomarker assessment
Studies that assessed inflammation related (pro-and antiinflammatory) biomarker levels for protein or RNA were included in the review.
| Data collection and analysis
| Selection of studies
All citations retrieved through the search strategy were downloaded to a common file, and duplicates were excluded. Two authors (E.H. and L.R.) independently screened the title and abstracts of all unique citations and selected those that were potentially relevant for full-text reading. The studies that fulfilled the aforementioned selection criteria were included in the review.
| Data extraction
A specific data extraction form was created for this study to collect the following information: study identification (author, year, and journal of publication), biomarker(s), assay type, gestational tissue studied, and the findings and or phenotype. Two authors (E.H. and L.R.) independently extracted data from the studies, compared their findings, resolved disagreements through discussion, and produced a single final form for each included study.
| Quality assessment
There were no well-validated quality assessment tools available for basic science research at the time of this review. Therefore, we developed a quality assessment tool, which was adapted from another quality assessment tool 10 to rate the quality as low, acceptable, or high (Table 1) . We assessed each included study for the value of the hypothesis, the strength of study design (description of population studied, inclusion/exclusion criteria, definition of phenotype studied), description of samples (collection, processing, and storage), and reagents used, the details of the methods section 
| Data synthesis
We present data from each study in a descriptive format and created a table with all the inflammatory biomarker phenotypes of term labor in each gestational tissue compartment. We then identified the biomarkers that overlap between the compartments to produce a list of the biomarkers common and unique to each of the gestational tissue compartments at the time of term labor.
| RESULTS
The electronic search yielded 3807 citations, which were reduced to 3712 after the exclusion of duplicates. After title and abstract screening, 3535 citations were excluded, and 177 were selected for full-text
reading. An additional 5 studies were excluded after a full-text review (Table 2 ). A total of 172 studies fulfilled the selection criteria and were included in the review and data analysis ( Figure 1 ).
| Main characteristics of studies
The main characteristics and findings of the included studies are summarized in Table S2 . (Table 3) .
| Methods used for biomarker determination
Biomarker measurements were undertaken by investigators using 
| Main findings
The number of participants (number of samples or subjects) per study ranged from 1 to 88; most studies included >10 healthy women at term. The number of women studied in term labor ranged from 1 to 44, with an average of 10; the number of women at term not in labor ranged from 3 to 44, with an average of 10.
The majority of included studies reported on more than one tissue, biomarker, and assay types. As shown in Table 3 , we found 106 studies that reported on amnion, 96 on chorion, 81 on decidua, 40 on placenta, and 53 on myometrium. Clinical specimens (specimens collected and processed right after delivery and assayed for markers)
constituted 280 of our data points, whereas 175 were based on in vitro culture-based analysis. In the latter group, tissues were collected after normal term in labor and/or term not in labor deliveries, and biomarkers produced were assayed (for protein or mRNA) after culturing them in vitro. (Figure 2 ). Seven T A B L E 1 Quality assessment tool template used for determining the quality of reports included for systematic review
Quality assessment
1. Question/objective sufficiently described?
2. Design appropriate to answer study question?
3. Samples, reagents, assays sufficiently described?
4. Methods described in sufficient detail?
5. Study can be easily replicated?
6. Sample/experiment number sufficient for internal validity? 
| Quality assessment
Based on the quality assessment tool that we developed (Table 1) , 121 articles (70%) were graded as being of high quality, 46 (27%) of acceptable quality, and 5 (3%) of low quality (Figure 3 ). The domains with the lowest quality scores were having an appropriate sample size for internal validity and replicability of study. The domains with the highest quality scores were in sufficiently describing the question/objective and having results, which support the conclusion.
In summary, we identified a unique set of biomarker in each individual compartment as well as biomarkers that are common to all compartments at the time of term labor.
| DISCUSSION
Increased inflammatory load in gestational tissues is a major contributor to events culminating in human parturition. IL-6 is a well-studied inflammatory cytokine documented to present with intra-uterine infection, 11-13 preterm labor, 14 and term labor. In our review, of the 27 articles that reported on IL-6, 13 articles reported on IL-6 protein, 12 reported on IL-6 mRNA, and 2 that reported on both protein and mRNA in various gestational tissues. An increase in IL-6 protein was reported in all gestational tissues at the time of term labor or after in vitro stimulation. is cytokine common to all gestational tissues at the time of term labor and its functional role is difficult to assess. It is likely that IL-6 functions as a biomarker of overall and nonspecific inflammation and not necessarily indicative of an underlying mechanism.
The discrepancy in data is due to multiple facts; in vitro data are often generated using not in labor tissues in culture stimulated with specific stimulants that not always mimic normal labor-associated signals, but often resemble infectious or other risk-associated stimuli 
IL-8 is another well-known inflammatory cytokine which is
known to have chemotactic properties. [41] [42] [43] [44] Our review yielded 33
articles which reported on IL-8; 9 of the articles reported on IL-8
Results of quality assessment of included reports. Q1-Q10 correspond to questions 1-10 as listed in Table 1 . The Y axis is the value assigned for the component question for the study evaluated, and the x axis is the number of high, acceptable, and low-quality studies in each response category placental explants between non-labor and labor samples. Based on the overall findings, we conclude that IL-8 levels are increased in gestational tissues at term labor. The discrepancies reported in IL-6 literature may apply for IL-8 and all other cytokine reporting as well.
Quality assessment
TNF-α is an inflammatory cytokine commonly increased at the time of infection and is known to increase prostaglandin production in gestational tissues 50, 58 and can activate the NF-κβ signaling pathway. 59 Our review found 13 articles that reported on TNF-α. Five articles reported on TNF-α protein, 5 reported on mRNA production, and 3 reported on both protein and mRNA productions from term labor tissues or simulated in vitro labor. The overall consensus was an increase in TNF-α protein. showed that TNF-α protein was increased in choriodecidua explants after treatment with LPS and that TNF-α induced production of IL-1β, PGE2 and IL-10 from the explants.
Prostaglandin E 2 is a common prostaglandin present at the time of term labor, which contributes to uterotonic effects and cervical ripening. 63, 64 We found 28 articles that reported on PGE 2 in our gestational tissues of interest. There were 28 articles that reported on PGE 2 protein levels. The majority of articles reviewed found an increase in PGE 2 protein at term labor or with in vitro simulated labor. The results for the response of IL-1β in the placenta at the time of labor were varied. Keelan et al found that there was no significant change in IL-1β protein levels with labor in the placenta, 7 and Mitchell et al 88 reported no stimulation of IL-1β production from placental explants after treatment with LPS. While Turner et al found that there was no difference in the production of IL-1β protein by placental fragments from term labor and not in labor, but placental IL-1β production was more sensitive to stimulation with TNF-α after labor. 22 Yadav et al also found an increased production of IL-1β by placental explants after treatment with SP-D. 23 In general, it appears that IL-1β is a pro-labor biomarker in all the tissues evaluated in this review, but its utility as a marker in the placenta may be more limited.
Cyclooxygenase-2 is a cyclooxygenase that is involved in prostaglandin production. 106 showed that COX-2 was higher in the lower myometrium than the upper in labor, which may reflect the role of COX-2 in the production of prostaglandins to ripen the cervix.
Human cationic antimicrobial peptide 18 (hCAP-18) is a cationic host defense peptide which had immunomodulatory properties.
hCAP18 is a cathelicidin which is commonly found at sites of inflammation and protects against bacteria by inducing cytokine release and chemotaxis (29Lim 2015). 29 We reviewed 1 article that reported on hCAP18 by Lim et al in 2015 that found an increase in hCAP18 protein with term labor fetal membranes, cytotrophoblast, and myometrium. They also found that treatment of membranes and myometrium with hCAP18 lead to an increase in IL-6 and TNF-α.
29
There is a paucity of articles about hCAP18, and it seems prudent to investigate hCAP18's role in parturition further as it is reported in all term samples.
It is interesting to note that all the common biomarkers reported in all tissues reported here are pro-inflammatory type and no common anti-inflammatory (eg, IL-2, IL-4, IL-10, and TGF-β) biomarkers have been reported. Several anti-inflammatory cytokines and growth factors have been associated with normal parturition. This is likely not due to lack of common anti-inflammatory markers in these tissues but demonstrates a generalized bias toward examination of pro-inflammatory factors. We speculate that a balance between pro-and anti-inflammatory cytokines is essential to maintain pregnancy. Higher loads of common pro-inflammatory biomarkers in all gestational tissues signify their harmonious functional role in promoting parturition. The biomarkers that are unique to each of the compartments have their own tissue-specific functions, which may or may not be linked to parturition but linked to maintenance of pregnancy.
In summary, our extensive review of the literature on biomarkers of term labor identified a unique biomarker profile in all gestational tissues. Synthesis of this knowledge will serve to help future research in many ways. Feto-maternal signals that can increase these common markers or promote their imbalance can be the focus of future studies to better understand the mechanisms initiating human parturition.
Similarly, understanding the functional role of unique markers in each of the tissues during pregnancy and in preparing for parturition will be of significant value.
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